NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, announced that Stephen Willard, J.D., Chief Executive Officer and Dr. Jonathan Javitt, Chief Scientist of NRx Pharmaceuticals, will present a company overview at the H.C. Wainwright 25th Annual Global Investment Conference.
September 7, 2023
· 3 min read